Fate Therapeutics, Inc. — Cash Flow Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Cash Flow
Cash Flow by Activity
Operating Cash Flow↓-1.4% -$459K
$-34M
Free Cash Flow↓-1116.3% -$1M
$-1M
Investing Cash Flow↑+21.1% +$5M
$28M
Financing Cash Flow↓-46.0% -$1M
$2M
Capex↑+1116.3% +$1M
$1M
Stock Buybacks
—
Stock-Based Comp
—
Debt Issued
—
Debt Repaid
—
D&A↓-36.4% -$2M
$3M
SBC Allocated Expense↓-39.4% -$4M
$6M